PERSONALIZED SURGICAL MANAGEMENT OF CRANIOSYNOSTOSIS IN CHILDREN USING ADVANCED MSCT MORPHOMETRY AND RISK STRATIFICATION MODELS

This study evaluates the effectiveness of a personalized approach to surgical treatment of craniosynostosis using enhanced MSCT morphometric protocols and risk stratification. A total of 120 pediatric patients aged 2 to 24 months were examined. Morphometric algorithms based on 14 key cranial parameters enabled precise classification of craniosynostosis types. Risk models identified high-risk patients with a preoperative neurological deficit rate of 18.7%. Radiation dose optimization led to a 35% dose reduction (average CTDIvol: 11.4 mGy). Surgical outcomes improved significantly with this approach, showing a 91.7% rate of excellent cosmetic results and a neurological improvement rate of 85% after 12 months.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-22
DOI
https://doi.org/10.5281/zenodo.15261161
Primary Topic
Craniofacial Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PERSONALIZED SURGICAL MANAGEMENT OF CRANIOSYNOSTOSIS IN CHILDREN USING ADVANCED MSCT MORPHOMETRY AND RISK STRATIFICATION MODELS

Zenodo (CERN European Organization for Nuclear Research)
Craniofacial Disorders and Treatments
article

PERSONALIZED SURGICAL MANAGEMENT OF CRANIOSYNOSTOSIS IN CHILDREN USING ADVANCED MSCT MORPHOMETRY AND RISK STRATIFICATION MODELS

article en

Abstract

This study evaluates the effectiveness of a personalized approach to surgical treatment of craniosynostosis using enhanced MSCT morphometric protocols and risk stratification. A total of 120 pediatric patients aged 2 to 24 months were examined. Morphometric algorithms based on 14 key cranial parameters enabled precise classification of craniosynostosis types. Risk models identified high-risk patients with a preoperative neurological deficit rate of 18.7%. Radiation dose optimization led to a 35% dose reduction (average CTDIvol: 11.4 mGy). Surgical outcomes improved significantly with this approach, showing a 91.7% rate of excellent cosmetic results and a neurological improvement rate of 85% after 12 months.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 54%
Craniofacial Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

PERSONALIZED SURGICAL MANAGEMENT OF CRANIOSYNOSTOSIS IN CHILDREN USING ADVANCED MSCT MORPHOMETRY AND RISK STRATIFICATION MODELS · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS